39 related articles for article (PubMed ID: 13065190)
1. [Intravenous iron therapy with ferrum injectabile Vitis].
PRIBILLA W
Medizinische; 1952 Jun; 2():53-6. PubMed ID: 14940483
[No Abstract] [Full Text] [Related]
2. [Iron transport in the blood after peroral, intravenous and intramuscular iron administration].
KLEIN E; FRANKEN FH; HIRCHE H
Klin Wochenschr; 1959 Mar; 37(5):244-9. PubMed ID: 13642749
[No Abstract] [Full Text] [Related]
3. [The passage of intravenously injected iron from the blood stream].
OVERKAMP H
Z Gesamte Exp Med; 1952; 120(1):86-95. PubMed ID: 13057308
[No Abstract] [Full Text] [Related]
4. [Intravenous iron].
DUFRESNE RR
Union Med Can; 1952 Jun; 81(6):697-8. PubMed ID: 13005802
[No Abstract] [Full Text] [Related]
5. [Tolerance of intravenous iron application].
GOLDECK H; REMY D; MEYER F
Arztl Wochensch; 1952 May; 7(21):489-90. PubMed ID: 14952397
[No Abstract] [Full Text] [Related]
6. Plasma iron levels after the intravenous administration of different iron preparations.
NISSIM JA
J Physiol; 1952 Dec; 118(4):63P-64P. PubMed ID: 13023666
[No Abstract] [Full Text] [Related]
7. [Irritative effects of intravenous administration of iron-glucose solutions].
WIESENER H
Dtsch Med J; 1952 Jun; 3(11-12):253-4. PubMed ID: 12979956
[No Abstract] [Full Text] [Related]
8. [The behavior of intravenously administered iron in the organism].
LINTZEL W
Arztl Forsch; 1953 Mar; 7(3):I/134-6. PubMed ID: 13065190
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review.
Daniilidis A; Panteleris N; Vlachaki E; Breymann C; Assimakopoulos E
J Obstet Gynaecol; 2018 May; 38(4):443-447. PubMed ID: 29057687
[TBL] [Abstract][Full Text] [Related]
10. Intravenous iron therapy in renal failure: friend and foe?
Afzali B; Goldsmith DJ
J Nephrol; 2004; 17(4):487-95. PubMed ID: 15372409
[TBL] [Abstract][Full Text] [Related]
11. Iron Treatment Strategies in Nondialysis CKD.
Macdougall IC
Semin Nephrol; 2016 Mar; 36(2):99-104. PubMed ID: 27236130
[TBL] [Abstract][Full Text] [Related]
12. Safety aspects of parenteral iron in patients with end-stage renal disease.
Sunder-Plassmann G; Hörl WH
Drug Saf; 1997 Oct; 17(4):241-50. PubMed ID: 9352960
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
